An important, limitation of this study, is that we found no significant difference in long-term surgical outcomes between patients with high and low expression of EZH2 (p = 0.1408), because there were only three patients whose cause of death was pancreatic IPMN after surgery. Here, EZH2 is linked to pancreatic intraductal papillary-mucinous neoplasm.